Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats

European Journal of Pharmacology

Volumn 557, Issue 2-3, 2007, Pages 178-185

  De Gennaro Colonna, Vito ^a   Bonomo, Sara ^a   Ferrario, Paolo ^a   Bianchi, Mauro ^a   Berti, Marco ^a   Guazzi, Marco ^a   Manfredi, Barbara ^a   Muller, Eugenio E ^a   Berti, Ferruccio ^a   Rossoni, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

(Rat); Asymmetric dimethylarginine; Endothelial dysfunction; Myocardial ischemia reperfusion

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENDOTHELIAL DYSFUNCTION; HEART; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; AORTA; ARGININE; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEART RATE; MALE; MYOCARDIAL REPERFUSION INJURY; NITRATES; NITRITES; PERFUSION; RATS; RATS, WISTAR; RNA, MESSENGER; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION;

EID: 33846580547     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.034     Document Type: Article

References (35)

1. Bergmeyer H.U., Rich W., Butter H., Schmidt E., Hillman G., and Kreuz F.H. Standardization of methods for estimation of enzyme activity in biological fluids. Z. Klin. Chem. Klin. Biochem. 8 (1970) 658-660
2. Boger R.H., Bode-Boger S.M., Thiele W., Junker W., Alexander K., and Frolich J.C. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95 (1997) 2068-2074
3. Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., and Cooke J.P. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
4. Boger R.H., Maas R., Schulze F., and Schwedhelm E. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin. Chem. Lab. Med. 43 (2005) 1124-1129
5. Brahms H., Raymackers J., Union A., de Keyser F., Meheus L., and Luhrmann R. The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J. Biol. Chem. 275 (2000) 17122-17129
6. G-nitro l-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72 (1993) 387-395
7. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
8. Cooke J.P. Does ADMA cause endothelial dysfunction?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2032-2037
9. G,dimethyl-l-arginine and their reversibility by vasodilators in conscious rats. Br. J. Pharmacol. 110 (1993) 1457-1464
10. 15N nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
11. Hattori Y., Akimoto K., Murakami Y., and Kasai K. Pyrrolidine dithiocarbamate inhibits cytokine-induced VCAM-1 gene expression in rat cardiac myocytes. Mol. Cell. Biochem. 177 (1997) 177-181
12. Heim K.F., Thomas G., and Ramwell P.W. Effect of substituted arginine compounds on superoxide production in the rabbit aorta. J. Pharmacol. Exp. Ther. 257 (1991) 1130-1135
13. Henry P.D., Schuchleib R., Davis J., Weiss E.S., and Sobel B.E. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am. J. Physiol. 233 (1977) H677-H684
14. Hingorani A.D., Cross J., Kharbanda R.K., Mullen M.J., Bhagat K., Taylor M., Donald A.E., Palacios M., Griffin G.E., Deanfield J.E., MacAllister R.J., and Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102 (2000) 994-999
15. Hohorst H.J. l-(+)-lactate. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1963), Academic Press Inc., New York, NY 215-219
16. Kai H., Kanaide H., Matsumoto T., and Nakamura M. 8-bromoguanosine 3′:5′-cyclic monophosphate decreases intracellular free calcium concentrations in cultured vascular smooth muscle cells from rat aorta. FEBS Lett. 221 (1987) 284-288
17. Kielstein J.T., and Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?. Am. J. Kidney Dis. 46 (2005) 186-202
18. Kobayashi N., Kobayashi K., Hara K., Higashi T., Yanaka H., Yagi S., and Matsuoka H. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am. J. Hypertens. 12 (1999) 483-491
19. Kurose I., Wolf R., Grisham M.B., and Granger D.N. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am. J. Physiol. 268 (1995) H2224-H2231
20. Leiper J.M. The DDAH-ADMA-NOS pathway. Ther. Drug Monit. 27 (2005) 744-746
21. Leiper J.M., and Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur. J. Clin. Pharmacol. 62 (2006) 33-38
22. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R., Hodson H., Whitley G., and Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119 (1996) 1533-1540
23. McCarty M.F. Vascular endothelium in the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine- an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. Med. Hypotheses 63 (2004) 699-708
24. Panza J.A., Quyyumi A.A., Brush J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323 (1990) 22-27
25. Roberts L.J., and Morrow J.D. Measurements of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28 (2000) 505-513
26. Rossoni G., Berti F., Bernareggi M., Villa L., Agozzino S., Cereda R., Giuliani P., and Mizrahi J. Protective effects of ITF 296 in the isolated rabbit heart subjected to global ischemia. J. Cardiovasc. Pharmacol. 26 (1995) S44-S52
27. Rossoni G., De Gennaro Colonna V., Bernareggi M., Polvani G.L., Müller E.E., and Berti F. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J. Cardiovasc. Pharmacol. 32 (1998) 260-265
28. Rossoni G., Berti M., De Gennaro Colonna V., Bernareggi M., Del Soldato P., and Berti F. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vivo and in vitro experiments in the rabbit. Ital. Heart J. 1 (2000) 146-155
29. Rossoni G., Manfredi B., Del Soldato P., and Berti F. The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion. J. Pharmacol. Exp. Ther. 310 (2004) 555-562
30. Segarra G., Medina P., Ballester R.M., Lluch P., Aldasoro M., Vila J.M., Lluch S., and Pelligrino D.A. Effects of some guanidino compounds on human cerebral arteries. Stroke 30 (1999) 2206-2210
31. Segarra G., Medina P., Vila J.M., Chuan P., Domenech C., Torondel B., and Lluch A. Inhibition of nitric oxide activity by arginine analogs in human renal arteries. Am. J. Hypertens. 14 (2001) 1142-1148
32. Suda O., Tsutsui M., Morishita T., Tasaki H., Ueno S., Nakata S., Tsujimoto T., Toyohira Y., Hayashida Y., Sasaguri Y., Ueta Y., Nakashima Y., and Yanagihara N. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1682-1688
33. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal. Biochem. 303 (2002) 131-137
34. ω-nitro l-arginine benzyl ester, a potent irreversible inhibitor of endothelium dependent relaxation. Biochem. Biophys. Res. Commun. 179 (1991) 1677-1682
35. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575